Experimental tumor injection shows promise in early cancer trial
Disease control
Recruiting now
This early-phase study tests an experimental drug called VAX014, which is injected directly into tumors to kill cancer cells. It is being studied alone and with standard immunotherapy drugs (nivolumab or pembrolizumab) in adults with advanced solid tumors who have tried other tre…
Phase: PHASE1 • Sponsor: Vaxiion Therapeutics • Aim: Disease control
Last updated May 11, 2026 20:40 UTC